参考文献/References:
[1] 王忠诚. 王忠诚神经外科学[M]. 武汉:湖北科学技术出版
社,2005. 1000-1003.
[2] Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silen-
cing and benefit from temozolomide in glioblastoma [J]. New
Engl J Med, 2005, 352(10): 997-1003.
[3] Nilsson J, Vallbo C, Guo D, et al. Cloning, characterization,
and expression of human LIG1 [J]. Biochem Biophys Res
Commun, 2001, 284(5): 1155-1161.
[4] Laederich MB, Funes-Duran M, Yen L, et al. The leucine-
rich repeat protein LRIG1 is a negative regulator of ErbB
family receptor tyrosine kinases [J]. J Biol Chem, 2004, 279
(45): 47050-47056.
[5] Wei YI, Fei YE, Guo D, et al. Expression and significance of
LRIG1 gene in human astrocytomas [J]. Chin-Germ J Clin
Oncol, 2005, 4(4): 225-228.
[6] Nilsson J, Starefeldt A, Henriksson R, et al. LRIG1 protein
in human cells and tissues [J]. Cell Tissue Res, 2003, 312
(1): 65-71.
[7] Hedman H, Henriksson R. LRIG inhibitors of growth factor
signalling-double-edged swords in human cancer [J]? Eur J
Cancer, 2007, 43: 676-682.
[8] Gur G, Rubin C, Katz M, et al. LRIG1 restricts growth factor
signaling by enhancing receptor ubiquitylation and degra-
dation [J]. EMBO J, 2004, 23(16): 3270-3281.
[9] Shattuck DL, Miller JK, Laederich M, et al. LRIG1 is a novel
negative regulator of the Met receptor and opposes Met and
Her2 synergy [J]. Mol Cell Biol, 2007, 27(5): 1934-1946.
[10] Ledda F, Bieraugel O, Fard SS, et al. Lrig1 is an endoge-
nous inhibitor of Ret receptor tyrosine kinase activation,
downstream signaling, and biological responses to GDNF [J].
J Neurosci, 2008, 28(1): 39-49.
[11] Krig SR, Frietze S, Simion C, et al. Lrig1 is an estrogen-
regulated growth suppressor and correlates with longer
relapse-free survival in ERα-positive breast cancer [J]. Mol
Cancer Res, 2011, 9(10): 1406-1417.
[12] 易 伟,叶 飞,郭东升,等. LRIG1基因在人星形细胞瘤
中的表达与意义[J]. 中国临床神经外科杂志,2006,11
(1):29-31.
[13] Goldoni S, Iozzo RA, Kay P, et al. A soluble ectodomain of
LRIG1 inhibits cancer cell growth by attenuating basal and
ligand-dependent EGFR activity [J]. Oncogene, 2007, 26
(3): 368-381.
[14] Yi W, Holmlund C, Nilsson J, et al. Paracrine regulation of
growth factor signaling by shed leucine-rich repeats and
immunoglobulin-like domains 1 [J]. Exp Cell Res, 2011,
317(4): 504-512.
[15] Johansson M1, Oudin A, Tiemann K, et al. The soluble form
of the tumor suppressor Lrig1 potently inhibits in vivo
glioma growth irrespective of EGF receptor status [J]. Neuro
Oncol, 2013, 15(9): 1200-1211.
相似文献/References:
[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(09):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(09):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(09):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性
癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(09):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞
增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(09):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(09):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(09):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(09):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
[11]刘 伟 简志宏 易 伟.sLRIG1与胶质瘤耐药细胞株化疗敏感性的关系[J].中国临床神经外科杂志,2016,(08):476.[doi:10.13798/j.issn.1009-153X.2016.08.011]
LIU Wei,JIAN Zhi-hong,YI Wei..Soluble LRIG1 improves sensitivity of multi-drug resistance glioma cells to chemotherapeutic agents[J].,2016,(09):476.[doi:10.13798/j.issn.1009-153X.2016.08.011]